Bicara Therapeutics Inc. Common Stock (BCAX) Ownership

$9.18

$0.14 (-1.5%)
Last update: 04:00 PM EST
Day's range
$9.06
Day's range
$9.46

Bicara Therapeutics Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 6.96 M $90.64 M   0.00% 12.77%
FMR LLC 05/12/2025 3.61 M $47.06 M   70.59% 6.63%
SIREN, L.L.C. 05/23/2025 3.27 M $42.57 M   -0.18% 6.00%
TPG GP A, LLC 05/15/2025 3.01 M $39.23 M   0.00% 5.53%
VESTAL POINT CAPITAL, LP 05/15/2025 2.77 M $36.08 M   290.00% 5.08%
OMEGA FUND MANAGEMENT, LLC 05/15/2025 2.20 M $28.73 M   0.00% 4.05%
BRAIDWELL LP 05/15/2025 2.16 M $28.18 M   8.10% 3.97%
DEEP TRACK CAPITAL, LP 05/15/2025 2.00 M $26.06 M   0.00% 3.67%
PRICE T ROWE ASSOCIATES INC /MD/ 05/14/2025 1.80 M $23.43 M   16.21% 3.30%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 1.39 M $18.17 M   84.00% 2.56%
JANUS HENDERSON GROUP PLC 05/15/2025 1.34 M $18.01 M   55.55% 2.47%
BLACKROCK, INC. 05/02/2025 1.34 M $17.49 M   6.37% 2.46%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 1.18 M $15.41 M   -45.62% 2.17%
MORGAN STANLEY 05/15/2025 1.15 M $15.01 M   185.95% 2.12%
VANGUARD GROUP INC 05/09/2025 1.09 M $14.22 M   0.05% 2.00%
BLACKSTONE INC. 05/15/2025 1.03 M $13.40 M   12.62% 1.89%
FIL LTD 05/12/2025 1.01 M $13.21 M   0.00% 1.86%
FORESITE CAPITAL MANAGEMENT VI LLC 05/15/2025 950.00 K $12.38 M   0.00% 1.74%
BAKER BROS. ADVISORS LP 05/15/2025 833.33 K $10.86 M   0.00% 1.53%
05/19/2025 643.38 K $8.38 M   0.00% 1.18%
AISLING CAPITAL MANAGEMENT LP 05/13/2025 568.92 K $7.41 M   0.00% 1.04%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 491.65 K $6.41 M   5.36% 0.90%
STATE STREET CORP 05/15/2025 370.13 K $4.82 M   21.46% 0.68%
SCHONFELD STRATEGIC ADVISORS LLC 05/15/2025 365.96 K $4.77 M   100.00% 0.67%
WOODLINE PARTNERS LP 05/15/2025 348.69 K $4.54 M   26.48% 0.64%
ORBIMED ADVISORS LLC 05/15/2025 298.30 K $3.89 M   0.00% 0.55%
NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD 05/15/2025 275.94 K $3.60 M   100.00% 0.51%
DAFNA CAPITAL MANAGEMENT LLC 05/15/2025 212.00 K $2.76 M   100.95% 0.39%
NORTHERN TRUST CORP 05/13/2025 154.21 K $2.01 M   -3.04% 0.28%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 153.00 K $1.99 M   -2.41% 0.28%
TD ASSET MANAGEMENT INC 05/07/2025 130.94 K $1.71 M   27.84% 0.24%
GOLDMAN SACHS GROUP INC 05/16/2025 125.70 K $1.64 M   -30.07% 0.23%
HEALTHINVEST PARTNERS AB 05/05/2025 119.83 K $1.56 M   100.00% 0.22%
DEUTSCHE BANK AG\ 05/09/2025 111.38 K $1.45 M   -0.97% 0.20%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 05/15/2025 68.56 K $893.35 K   135.30% 0.13%
UBS GROUP AG 05/13/2025 65.85 K $858.08 K   -67.14% 0.12%
STEMPOINT CAPITAL LP 05/15/2025 47.08 K $613.43 K   100.00% 0.09%
BANK OF NEW YORK MELLON CORP 04/29/2025 42.19 K $549.76 K   4.78% 0.08%
SCHRODER INVESTMENT MANAGEMENT GROUP 05/13/2025 41.66 K $558.24 K   100.00% 0.08%
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 05/07/2025 38.04 K $495.60 K   0.00% 0.07%
VICTORY CAPITAL MANAGEMENT INC 05/02/2025 34.43 K $448.62 K   100.00% 0.06%
JEFFERIES FINANCIAL GROUP INC. 05/08/2025 30.60 K $398.73 K   100.00% 0.06%
XTX TOPCO LTD 05/08/2025 28.45 K $370.74 K   4.09% 0.05%
MILLENNIUM MANAGEMENT LLC 05/15/2025 25.65 K $334.19 K   -93.35% 0.05%
05/12/2025 25.03 K $326.12 K   100.00% 0.05%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 24.90 K $324.47 K   100.00% 0.05%
RHUMBLINE ADVISERS 05/29/2025 23.02 K $299.92 K   21.10% 0.04%
JPMORGAN CHASE & CO 05/12/2025 21.79 K $283.98 K   -66.34% 0.04%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 21.52 K $280.37 K   1,075.79% 0.04%
BARCLAYS PLC 05/15/2025 20.27 K $264.00 K   -32.67% 0.04%

Bicara Therapeutics Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 98 institutional investors and hedge funds held shares of Bicara Therapeutics Inc. Common Stock. The most heavily invested institutionals were:

RA CAPITAL MANAGEMENT, L.P.: 6.96 M

FMR LLC: 3.61 M

Siren, L.L.C.: 3.27 M

TPG GP A, LLC: 3.01 M

Vestal Point Capital, LP: 2.77 M

Omega Fund Management, LLC: 2.2 M

81.29% of Bicara Therapeutics Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 43.82 M shares in the last 24 months. This purchase volume represents approximately $401.80 M in transactions.